Literature DB >> 14623736

Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor.

Keun-Hwa Jung1, Kon Chu, Sang-Wuk Jeong, Hee-Kwon Park, Hee-Joon Bae, Byung-Woo Yoon.   

Abstract

BACKGROUND: Cerebral cavernous malformations (CCMs) are reported to exhibit a wide range of dynamic patterns including growth, regression, and de novo formation, which generally show slow and steady courses. Although the pathogenesis of CCMs is not well known, vascular endothelial growth factor (VEGF) has been suggested as a possible mediating factor.
OBJECTIVES: To report CCMs showing rapid progression over a short period and to investigate these biological characteristics.
DESIGN: Experimental study.
SETTING: Tertiary referral center, neurology department. Patient A 40-year-old man was admitted because of a left-sided numbness, vertigo, and ataxia, which were attributed to a pontine hemorrhage. He had experienced a left-sided weakness 6 months before admission, and thereafter had complained of intermittent headache. Serial brain magnetic resonance images showed multiple intracerebral microhemorrhages throughout the cerebral hemispheres. A biopsy of the lesion confirmed the diagnosis of CCM. MAIN OUTCOME MEASURES: We investigated the expression of VEGF by immunohistochemistry of the biopsy specimen. Dynamic patterns of CCMs, obtained with spin-echo magnetic resonance images with gradient-echo sequences, were compared with serial serum VEGF concentrations, determined by enzyme-linked immunosorbent assay.
RESULTS: Immunohistochemistry of the specimen displayed increased VEGF expression. Serial magnetic resonance images during 7 months showed dynamic signal changes of the preexisting lesions and 15 de novo formations in many cortices. The VEGF level in serum increased during this dynamic period and became normal during the steady and resolving stages.
CONCLUSIONS: Cerebral cavernous malformations can be progressively deteriorating. The endothelial proliferation induced by VEGF is likely to be an important aspect of the pathogenetic mechanisms of CCMs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623736     DOI: 10.1001/archneur.60.11.1613

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  22 in total

1.  Chronic encapsulated intracerebral hematoma associated with cavernous malformation.

Authors:  Satoru Takeuchi; Kojiro Wada; Fumihiro Sakakibara; Kentaro Mori
Journal:  J Korean Neurosurg Soc       Date:  2014-02-28

2.  Splenic hemangiopericytoma and serosal cavernous hemangiomatosis of the adjacent colon.

Authors:  Tuncay Yilmazlar; Turkay Kirdak; Omer Yerci; Saduman B Adim; Ozkan Kanat; Osman Manavoglu
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  Gyrate: CCM3 dances with a different angiogenic partner.

Authors:  Laura A Dyer; Andrea L Portbury; Cam Patterson
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

4.  Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.

Authors:  Romuald Girard; Hussein A Zeineddine; Maged D Fam; Anoop Mayampurath; Ying Cao; Changbin Shi; Robert Shenkar; Sean P Polster; Michael Jesselson; Ryan Duggan; Abdul-Ghani Mikati; Gregory Christoforidis; Jorge Andrade; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Transl Stroke Res       Date:  2017-08-17       Impact factor: 6.829

5.  Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.

Authors:  Joycelyn Wüstehube; Arne Bartol; Sven S Liebler; René Brütsch; Yuan Zhu; Ute Felbor; Ulrich Sure; Hellmut G Augustin; Andreas Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-24       Impact factor: 11.205

6.  Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.

Authors:  Romuald Girard; Hussein A Zeineddine; Janne Koskimäki; Maged D Fam; Ying Cao; Changbin Shi; Thomas Moore; Rhonda Lightle; Agnieszka Stadnik; Kiranj Chaudagar; Sean Polster; Robert Shenkar; Ryan Duggan; David Leclerc; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Circ Res       Date:  2018-05-02       Impact factor: 17.367

7.  KRIT1 regulates the homeostasis of intracellular reactive oxygen species.

Authors:  Luca Goitre; Fiorella Balzac; Simona Degani; Paolo Degan; Saverio Marchi; Paolo Pinton; Saverio Francesco Retta
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

Review 8.  Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.

Authors:  Aubrey C Chan; Dean Y Li; Michel J Berg; Kevin J Whitehead
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

9.  Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.

Authors:  Wuttipong Tirakotai; Sandra Fremann; Niels Soerensen; Wolfgang Roggendorf; Adrian M Siegel; Hans Dieter Mennel; Yuan Zhu; Helmut Bertalanffy; Ulrich Sure
Journal:  Childs Nerv Syst       Date:  2006-02-18       Impact factor: 1.475

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.